H.R.10369 — Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

Sponsor: Rep. Mackenzie, Ryan [R-PA-7] (R-PA)
Last recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. — September 14, 2026
Introduced: 2026-09-14
Chamber: house